Announced
Completed
Financials
Tags
Domestic
Biotechnology
biotechnology company
Single Bidder
Private
Majority
Friendly
Acquisition
United States
Private Equity
Completed
Synopsis
SK Capital, a private investment firm focused on the specialty materials, chemicals and pharmaceuticals sectors, completed the acquisition of the Blow-Fill-Seal Sterile CDMO business of Catalent, a pharmaceutical company. Financial terms were not disclosed. ”Paul is a CDMO industry veteran who brings sterile production experience and contemporary leadership skills to ensure an environment committed to operational excellence, customer delight, innovation and a partnership-driven approach for Woodstock’s customers, suppliers and employees,” Aaron Davenport, SK Capital Managing Director.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.